
BMS-309403
CAS No. 300657-03-8
BMS-309403( BMS309403 )
Catalog No. M13930 CAS No. 300657-03-8
A potent, selective, cell-permeable and orally active inhibitor of FABP4 (Fatty acid binding protein 4) with Ki of < 2 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 27 | In Stock |
![]() ![]() |
5MG | 43 | In Stock |
![]() ![]() |
10MG | 77 | In Stock |
![]() ![]() |
25MG | 149 | In Stock |
![]() ![]() |
50MG | 194 | In Stock |
![]() ![]() |
100MG | 252 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameBMS-309403
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective, cell-permeable and orally active inhibitor of FABP4 (Fatty acid binding protein 4) with Ki of < 2 nM.
-
DescriptionA potent, selective, cell-permeable and orally active inhibitor of FABP4 (Fatty acid binding protein 4) with Ki of < 2 nM; improves endothelial function, phosphorylated and total eNOS and reduces plasma triglyceride levels but does not affect endothelium-independent relaxations in mice; exhibits an effective therapeutic activity against severe atherosclerosis and type 2 diabetes in mouse models.
-
In Vitro——
-
In VivoAnimal Model:C57BL/6J mice (ApoE?/? mice)Dosage:15 mg/kg Administration:Chronic treatment ; daily for 6 weeks Result: Significantly increased the phosphorylated eNOS (Ser1177) and total eNOS but not the phosphorylated to total eNOS ratio in aortae of 18 weeks old ApoE?/? mice.
-
SynonymsBMS309403
-
PathwayMembrane Transporter/Ion Channel
-
TargetFABP
-
RecptorFABP4|FABP3|FABP5
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number300657-03-8
-
Formula Weight474.55
-
Molecular FormulaC31H26N2O3
-
Purity>98% (HPLC)
-
Solubility100 mM in DMSO
-
SMILESCCc1c(c(nn1c2ccccc2c3cccc(c3)OCC(=O)O)c4ccccc4)c5ccccc5
-
Chemical Name2-[[2'-(5-ethyl-3,4-diphenyl-1H-pyrazol-1-yl)[1,1'-biphenyl]-3-yl]oxy]-acetic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Furuhashi M, et al. Nature. 2007 Jun 21;447(7147):959-65.
2. Lee MY, et al. Br J Pharmacol. 2011 Apr;162(7):1564-76.
3. Sulsky R, et al. Bioorg Med Chem Lett. 2007 Jun 15;17(12):3511-5.
molnova catalog



related products
-
SBFI-26
SBFI-26 (SBFI26) is a small molecule inhibitor of epidermal- and brain-specific FABP5 and FABP7 that effectively increases anandamide signaling.
-
FABP4 inhibitor 1
A potent, selective FABP4 inhibitor with Ki of 30 nM.
-
FABPs ligand 6
FABPs ligand 6 (MF6) is a selective inhibitor of FABP5 and FABP7 that reduces levels of oxidative stress in the mouse spinal cord as well as lipopolysaccharide-stimulated interleukin-1β and tumor necrosis factor α accumulation in primary astrocyte cultures.